Skip to content
2000
image of Unlocking the Role of Exosomal ncRNAs in Colorectal Cancer: Molecular Insights and Clinical Promise

Abstract

Colorectal cancer (CRC) continues to be a substantial cause of cancer-related fatality globally, necessitating improved diagnostic and therapeutic strategies. Exosomes, small extracellular vesicles that facilitate intercellular communication, as key mediators in CRC progression by transporting bioactive molecules, including non-coding RNAs (ncRNAs). These exosomal ncRNAs (exo-ncRNAs) participate in regulating gene expression, tumor proliferation, metastasis, chemoresistance, and immune escape. Exo-ncRNAs show distinct patterns in CRC, making them potential non-invasive indicators for early detection and prognosis. Additionally, the potential of exosome-based therapies, including engineered exosomal RNA delivery, offers new avenues for precision oncology. However, addressing challenges, such as standardization of exosome isolation methods, clinical validation, and mechanistic elucidation, is necessary before their full clinical implementation. This article offers a comprehensive synthesis of the recent knowledge of exo-ncRNAs in CRC, emphasizing their biological functions, molecular mechanisms, and translational potential in diagnostics and therapeutics. Future research integrating artificial intelligence and multi-omics approaches may further enhance the clinical utility of exo-ncRNAs, advancing precision medicine in CRC management.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128415658251125090944
2026-02-26
2026-03-02

  • From This Site

    /content/journals/cpd/10.2174/0113816128415658251125090944
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Tufail M. Wu C. Hussain M.S. Dietary, addictive and habitual factors, and risk of colorectal cancer. Nutrition 2024 120 112334 10.1016/j.nut.2023.112334 38271761
    [Google Scholar]
  2. Sawicki T. Ruszkowska M. Danielewicz A. Niedźwiedzka E. Arłukowicz T. Przybyłowicz K.E. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers 2021 13 9 2025 10.3390/cancers13092025 33922197
    [Google Scholar]
  3. Puzzono M. Mannucci A. Grannò S. The role of diet and lifestyle in early-onset colorectal cancer: A systematic review. Cancers 2021 13 23 5933 10.3390/cancers13235933 34885046
    [Google Scholar]
  4. Read B. Sylla P. Aggressive colorectal cancer in the young. Clin. Colon Rectal Surg. 2020 33 5 298 304 10.1055/s‑0040‑1713747 32968365
    [Google Scholar]
  5. Fotsitzoudis C. Koulouridi A. Messaritakis I. Cancer-associated fibroblasts: The origin, biological characteristics and role in cancer - A glance on colorectal cancer. Cancers 2022 14 18 4394 10.3390/cancers14184394 36139552
    [Google Scholar]
  6. Zhang L. Shay J.W. Multiple roles of APC and its therapeutic implications in colorectal cancer. J. Natl. Cancer Inst. 2017 109 8 109 10.1093/jnci/djw332 28423402
    [Google Scholar]
  7. Li J. Ma X. Chakravarti D. Shalapour S. DePinho R.A. Genetic and biological hallmarks of colorectal cancer. Genes Dev. 2021 35 11-12 787 820 10.1101/gad.348226.120 34074695
    [Google Scholar]
  8. Nguyen L.H. Goel A. Chung D.C. Pathways of colorectal carcinogenesis. Gastroenterology 2020 158 2 291 302 10.1053/j.gastro.2019.08.059 31622622
    [Google Scholar]
  9. Nur Ay. Therapeutic targeting of molecular pathways in colorectal cancer. Exp. Oncol. 2022 44 1 2 6 35548959
    [Google Scholar]
  10. Huang B. An H. Gui M. Qingjie Fuzheng Granule prevents colitis-associated colorectal cancer by inhibiting abnormal activation of NOD2/NF-κB signaling pathway mediated by gut microbiota disorder. Chin. Herb. Med. 2025 17 3 500 512 10.1016/j.chmed.2025.04.001 40734913
    [Google Scholar]
  11. Li J. Zhang G. Liu C.G. The potential role of exosomal circRNAs in the tumor microenvironment: Insights into cancer diagnosis and therapy. Theranostics 2022 12 1 87 104 10.7150/thno.64096 34987636
    [Google Scholar]
  12. Wu P. Zhang B. Ocansey D.K.W. Xu W. Qian H. Extracellular vesicles: A bright star of nanomedicine. Biomaterials 2021 269 120467 10.1016/j.biomaterials.2020.120467 33189359
    [Google Scholar]
  13. Ahad Mir P. Hussain M.S. Ahmad Khanday M. Mohi-Ud-Din R. Pottoo F.H. Hasssan Mir R. Immunomodulatory roles of mesenchymal stem cell-derived extracellular vesicles: A promising therapeutic approach for autoimmune diseases. Curr. Stem Cell Res. Ther. 2024 10.2174/011574888X341781241216044130 39757602
    [Google Scholar]
  14. Li X. Wang Q. Wang R. Roles of exosome genomic DNA in colorectal cancer. Front. Pharmacol. 2022 13 923232 10.3389/fphar.2022.923232 35721181
    [Google Scholar]
  15. Da M. Jiang H. Xie Y. Jin W. Han S. The biological roles of exosomal long non-coding RNAs in cancers. OncoTargets Ther. 2021 14 271 287 10.2147/OTT.S281175 33488093
    [Google Scholar]
  16. Wang J. Tao X. Liu Z. Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications. Pharmacol. Res. 2025 212 107596 10.1016/j.phrs.2025.107596 39800175
    [Google Scholar]
  17. Wang K. Ning S. Zhang S. Jiang M. Huang Y. Pei H. Extracellular matrix stiffness regulates colorectal cancer progression via HSF4. J. Exp. Clin. Cancer Res. 2025 44 30 10.1186/s13046‑025‑03297‑8
    [Google Scholar]
  18. Amirkhah R. Naderi-Meshkin H. Shah J. Dunne P. Schmitz U. The intricate interplay between epigenetic events, alternative splicing and noncoding RNA deregulation in colorectal cancer. Cells 2019 8 8 929 10.3390/cells8080929 31430887
    [Google Scholar]
  19. Elrebehy M.A. Al-Saeed S. Gamal S. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review. Int. J. Biol. Macromol. 2022 214 583 600 10.1016/j.ijbiomac.2022.06.134 35768045
    [Google Scholar]
  20. Duan W.W. Yang L.T. Liu J. A TGF‐β signaling‐related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci. Ther. 2024 30 4 e14489 10.1111/cns.14489 37850692
    [Google Scholar]
  21. Bakhsh T. Alhazmi S. Alburae N.A. Exosomal miRNAs as a promising source of biomarkers in colorectal cancer progression. Int. J. Mol. Sci. 2022 23 9 4855 10.3390/ijms23094855 35563246
    [Google Scholar]
  22. Boriachek K. Islam M.N. Möller A. Biological functions and current advances in isolation and detection strategies for exosome nanovesicles. Small 2018 14 6 10.1002/smll.201702153 29282861
    [Google Scholar]
  23. Song G. Zeng C. Li J. Exosome-based nanomedicines for digestive system tumors therapy. Nanomedicine 2025 20 10 1167 1180 10.1080/17435889.2025.2493037 40248953
    [Google Scholar]
  24. Di Bella M.A. Overview and update on extracellular vesicles: Considerations on exosomes and their application in modern medicine. Biology 2022 11 6 804 10.3390/biology11060804 35741325
    [Google Scholar]
  25. Liu M. Wen Z. Zhang T. Zhang L. Liu X. Wang M. The role of exosomal molecular cargo in exosome biogenesis and disease diagnosis. Front. Immunol. 2024 15 1417758 10.3389/fimmu.2024.1417758 38983854
    [Google Scholar]
  26. Jalaludin I. Lubman D.M. Kim J. A guide to mass spectrometric analysis of extracellular vesicle proteins for biomarker discovery. Mass Spectrom. Rev. 2023 42 2 844 872 10.1002/mas.21749 34747512
    [Google Scholar]
  27. Lin J. Li J. Huang B. Exosomes: Novel biomarkers for clinical diagnosis. ScientificWorldJournal 2015 2015 1 657086 10.1155/2015/657086 25695100
    [Google Scholar]
  28. Thompson A.G. Gray E. Heman-Ackah S.M. Extracellular vesicles in neurodegenerative disease - Pathogenesis to biomarkers. Nat. Rev. Neurol. 2016 12 6 346 357 10.1038/nrneurol.2016.68 27174238
    [Google Scholar]
  29. Gurunathan S. Kang M.H. Kim J.H. A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes. Int. J. Nanomedicine 2021 16 1281 1312 10.2147/IJN.S291956 33628021
    [Google Scholar]
  30. Mashouri L. Yousefi H. Aref A.R. Ahadi A. Molaei F. Alahari S.K. Exosomes: Composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol. Cancer 2019 18 1 75 10.1186/s12943‑019‑0991‑5 30940145
    [Google Scholar]
  31. Malki A. ElRuz R.A. Gupta I. Allouch A. Vranic S. Al Moustafa A.E. Molecular mechanisms of colon cancer progression and metastasis: Recent insights and advancements. Int. J. Mol. Sci. 2020 22 1 130 10.3390/ijms22010130 33374459
    [Google Scholar]
  32. Abida Alhuthali H.M. Alshehri J.M. Exosomes in infectious diseases: Insights into leishmaniasis pathogenesis, immune modulation, and therapeutic potential Naunyn-Schmiedeberg’s Archives of Pharmacology 2025 398 5 4913 4931 10.1007/s00210‑024‑03702‑7 39702600
    [Google Scholar]
  33. Gatta A.T. Carlton J.G. The ESCRT-machinery: Closing holes and expanding roles. Curr. Opin. Cell Biol. 2019 59 121 132 10.1016/j.ceb.2019.04.005 31132588
    [Google Scholar]
  34. Schuh A.L. Audhya A. The ESCRT machinery: From the plasma membrane to endosomes and back again. Crit. Rev. Biochem. Mol. Biol. 2014 49 3 242 261 10.3109/10409238.2014.881777 24456136
    [Google Scholar]
  35. Carlton J. The ESCRT machinery: A cellular apparatus for sorting and scission. Biochem. Soc. Trans. 2010 38 6 1397 1412 10.1042/BST0381397 21118097
    [Google Scholar]
  36. Krylova S.V. Feng D. The machinery of exosomes: Biogenesis, release, and uptake. Int. J. Mol. Sci. 2023 24 2 1337 10.3390/ijms24021337 36674857
    [Google Scholar]
  37. Andreu Z. Yáñez-Mó M. Tetraspanins in extracellular vesicle formation and function. Front. Immunol. 2014 5 442 10.3389/fimmu.2014.00442 25278937
    [Google Scholar]
  38. Weisgerber A.W. Mahmood A. Wehman A.M. Knowles M.K. Molecular regulation of multivesicular endosome fusion and exosome secretion. Exocytosis From Molecules to Cells. IOP Publishing Ltd 2022 15-1 15-28 10.1088/978‑0‑7503‑3771‑7
    [Google Scholar]
  39. Wei H. Chen Q. Lin L. Regulation of exosome production and cargo sorting. Int. J. Biol. Sci. 2021 17 1 163 177 10.7150/ijbs.53671 33390841
    [Google Scholar]
  40. Corrado C. Raimondo S. Chiesi A. Ciccia F. De Leo G. Alessandro R. Exosomes as intercellular signaling organelles involved in health and disease: Basic science and clinical applications. Int. J. Mol. Sci. 2013 14 3 5338 5366 10.3390/ijms14035338 23466882
    [Google Scholar]
  41. Huang H. Huang F. Liang X. Afatinib reverses EMT via inhibiting CD44-Stat3 axis to promote radiosensitivity in nasopharyngeal carcinoma. Pharmaceuticals 2022 16 1 37 10.3390/ph16010037 36678534
    [Google Scholar]
  42. Mola S. Pandolfo C. Sica A. Porta C. The macrophages-microbiota interplay in Colorectal Cancer (CRC)-related inflammation: Prognostic and therapeutic significance. Int. J. Mol. Sci. 2020 21 18 6866 10.3390/ijms21186866 32962159
    [Google Scholar]
  43. Melnik B.C. Stremmel W. Weiskirchen R. John S.M. Schmitz G. Exosome-derived MicroRNAs of human milk and their effects on infant health and development. Biomolecules 2021 11 6 851 10.3390/biom11060851 34200323
    [Google Scholar]
  44. Ahmadi M. Rezaie J. Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications. J. Transl. Med. 2020 18 1 249 10.1186/s12967‑020‑02426‑5 32571337
    [Google Scholar]
  45. Li X. Wang S. Mu W. Barry J. Han A. Carpenter R.L. Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p/PD-L1 pathway. J. Exp. Clin. Cancer Res. 2022 41 41 10.1186/s13046‑022‑02244‑1
    [Google Scholar]
  46. Hu W. Liu C. Bi Z.Y. Comprehensive landscape of extracellular vesicle-derived RNAs in cancer initiation, progression, metastasis and cancer immunology. Mol. Cancer 2020 19 1 102 10.1186/s12943‑020‑01199‑1 32503543
    [Google Scholar]
  47. Zhong Y. Li H. Li P. Exosomes: A new pathway for cancer drug resistance. Front. Oncol. 2021 11 743556 10.3389/fonc.2021.743556 34631581
    [Google Scholar]
  48. Howitt J. Hill A.F. Exosomes in the pathology of neurodegenerative diseases. J. Biol. Chem. 2016 291 52 26589 26597 10.1074/jbc.R116.757955 27852825
    [Google Scholar]
  49. Zhang G. Xia Y. Wan F. New perspectives on roles of alpha-synuclein in Parkinson’s disease. Front. Aging Neurosci. 2018 10 370 10.3389/fnagi.2018.00370 30524265
    [Google Scholar]
  50. Xiao T. Zhang W. Jiao B. Pan C.Z. Liu X. Shen L. The role of exosomes in the pathogenesis of Alzheimer’ disease. Transl. Neurodegener. 2017 6 1 3 10.1186/s40035‑017‑0072‑x 28184302
    [Google Scholar]
  51. Hade M.D. Suire C.N. Suo Z. Mesenchymal stem cell-derived exosomes: Applications in regenerative medicine. Cells 2021 10 8 1959 10.3390/cells10081959 34440728
    [Google Scholar]
  52. Ala M. The beneficial effects of mesenchymal stem cells and their exosomes on myocardial infarction and critical considerations for enhancing their efficacy. Ageing Res. Rev. 2023 89 101980 10.1016/j.arr.2023.101980 37302757
    [Google Scholar]
  53. Toh W.S. Zhang B. Lai R.C. Lim S.K. Immune regulatory targets of mesenchymal stromal cell exosomes/small extracellular vesicles in tissue regeneration. Cytotherapy 2018 20 12 1419 1426 10.1016/j.jcyt.2018.09.008 30352735
    [Google Scholar]
  54. Jeyaraman M. Muthu S. Gulati A. Jeyaraman N. G S P, Jain R. Mesenchymal stem cell-derived exosomes: A potential therapeutic avenue in knee osteoarthritis. Cartilage 2021 13 1_suppl 1572S 1585S 10.1177/1947603520962567 33016114
    [Google Scholar]
  55. Geisler S. Coller J. RNA in unexpected places: Long non-coding RNA functions in diverse cellular contexts. Nat. Rev. Mol. Cell Biol. 2013 14 11 699 712 10.1038/nrm3679 24105322
    [Google Scholar]
  56. Chan J.J. Tay Y. Noncoding RNA:RNA regulatory networks in cancer. Int. J. Mol. Sci. 2018 19 5 1310 10.3390/ijms19051310 29702599
    [Google Scholar]
  57. Lu T.X. Rothenberg M.E. MicroRNA. J. Allergy Clin. Immunol. 2018 141 4 1202 1207 10.1016/j.jaci.2017.08.034 29074454
    [Google Scholar]
  58. Ahmed E.A. Bhat R.S. Shaik J.P. MicroRNA gene expression profile of colorectal cancer in Saudi population. Int. J. Pharmacol. 2024 20 2 149 157 10.3923/ijp.2024.149.157
    [Google Scholar]
  59. Croce C.M. Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 2009 10 10 704 714 10.1038/nrg2634 19763153
    [Google Scholar]
  60. Aslan E.S. Yavas C. Akcali N. Eslamkhah S. Meral G. Batur L.K. The functional correlation between mir-16-5p and BIRC5 gene in colorectal cancer: Integrated analysis of transcriptomics and in vitro validation. Mol. Biol. Rep. 2025 52 1 252 10.1007/s11033‑025‑10355‑z 39976834
    [Google Scholar]
  61. Radwan A.F. Shaker O.G. El-Boghdady N.A. Senousy M.A. Association of MALAT1 and PVT1 variants, expression profiles and target miRNA-101 and miRNA-186 with colorectal cancer: Correlation with epithelial-mesenchymal transition. Int. J. Mol. Sci. 2021 22 11 6147 10.3390/ijms22116147 34200314
    [Google Scholar]
  62. Hassain A.S. Al-Khafaji H.M.A.H. Mohammed M.Q. The role of miRNA-4516 in regulating Bruton’s tyrosine kinase expression and colorectal cancer progression in a sample of Iraqi population. J. Biol. Res. 2025 98 1 10.4081/jbr.2025.12987
    [Google Scholar]
  63. Liu Z. Ma T. Duan J. Liu X. Liu L. MicroRNA 223 induced inhibition of the FBXW7 gene affects the proliferation and apoptosis of colorectal cancer cells via the Notch and Akt/mTOR pathways. Mol. Med. Rep. 2020 23 2 154 10.3892/mmr.2020.11793 33355365
    [Google Scholar]
  64. He B. Wang L. Zhou W. A fusion model to predict the survival of colorectal cancer based on histopathological image and gene mutation. Sci. Rep. 2025 15 1 9677 10.1038/s41598‑025‑91420‑2 40113813
    [Google Scholar]
  65. Hombach S. Kretz M. Non-coding RNAs: Classification, biology and functioning. Adv. Exp. Med. Biol. 2016 937 3 17 10.1007/978‑3‑319‑42059‑2_1 27573892
    [Google Scholar]
  66. Inamura K. Major tumor suppressor and oncogenic non-coding RNAs: Clinical relevance in lung cancer. Cells 2017 6 2 12 10.3390/cells6020012 28486418
    [Google Scholar]
  67. Ding D. Li C. Zhao T. Li D. Yang L. Zhang B. LncRNA H19/miR-29b-3p/PGRN axis promoted epithelial-mesenchymal transition of colorectal cancer cells by acting on wnt signaling. Mol. Cells 2018 41 5 423 435 29754471
    [Google Scholar]
  68. Zhang C. Wang L. Jin C. Long non-coding RNA Lnc-LALC facilitates colorectal cancer liver metastasis via epigenetically silencing LZTS1. Cell Death Dis. 2021 12 2 224 10.1038/s41419‑021‑03461‑w 33637680
    [Google Scholar]
  69. Du T. Gao Q. Zhao Y. Long non-coding RNA LINC02474 affects metastasis and apoptosis of colorectal cancer by inhibiting the expression of GZMB. Front. Oncol. 2021 11 651796 10.3389/fonc.2021.651796 33898319
    [Google Scholar]
  70. Bak R.O. Mikkelsen J.G. miRNA sponges: soaking up miRNAs for regulation of gene expression. Wiley Interdiscip. Rev. RNA 2014 5 3 317 333 10.1002/wrna.1213 24375960
    [Google Scholar]
  71. Haque S. Harries L. Circular RNAs (circRNAs) in health and disease. Genes 2017 8 12 353 10.3390/genes8120353 29182528
    [Google Scholar]
  72. Wei G. Zhu J. Hu H.B. Liu J.Q. Circular RNAs: Promising biomarkers for cancer diagnosis and prognosis. Gene 2021 771 145365 10.1016/j.gene.2020.145365 33346098
    [Google Scholar]
  73. Chen B. Hong Y. Gui R. N6-methyladenosine modification of circ_0003215 suppresses the pentose phosphate pathway and malignancy of colorectal cancer through the miR-663b/DLG4/G6PD axis. Cell Death Dis. 2022 13 9 804 10.1038/s41419‑022‑05245‑2 36127319
    [Google Scholar]
  74. Zhang W. Wang B. Lin Y. hsa_circ_0000231 promotes colorectal cancer cell growth through upregulation of CCND2 by IGF2BP3/miR-375 dual pathway. Cancer Cell Int. 2022 22 1 27 10.1186/s12935‑022‑02455‑8 35033075
    [Google Scholar]
  75. Zhaohui Liu Xiaoping Xu Dong Chen Circ_0022340 promotes colorectal cancer progression via HNRNPC/EBF1/SYT7 or miR-382-5p/ELK1 axis. Cell. Mol. Biol. 2022 68 7 107 116 10.14715/cmb/2022.68.7.18 36495510
    [Google Scholar]
  76. Tang J. Zhang C. Huang Y. CircRNA circ_0124554 blocked the ubiquitination of AKT promoting the skip lymphovascular invasion on hepatic metastasis in colorectal cancer. Cell Death Dis. 2021 12 3 270 10.1038/s41419‑021‑03565‑3 33723214
    [Google Scholar]
  77. Bachellerie J.P. Cavaillé J. Hüttenhofer A. The expanding snoRNA world. Biochimie 2002 84 8 775 790 10.1016/S0300‑9084(02)01402‑5 12457565
    [Google Scholar]
  78. Xing Y.H. Chen L.L. Processing and roles of snoRNA-ended long noncoding RNAs. Crit. Rev. Biochem. Mol. Biol. 2018 53 6 596 606 10.1080/10409238.2018.1508411 30252509
    [Google Scholar]
  79. Zhang X. Wang C. Xia S. The emerging role of snoRNAs in human disease. Genes Dis. 2023 10 5 2064 2081 10.1016/j.gendis.2022.11.018 37492704
    [Google Scholar]
  80. Yoshida K. Toden S. Weng W. SNORA21 – An oncogenic small nucleolar RNA, with a prognostic biomarker potential in human colorectal cancer. EBioMedicine 2017 22 68 77 10.1016/j.ebiom.2017.07.009 28734806
    [Google Scholar]
  81. Liu Y. Zhao C. Sun J. Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer. Bioengineered 2021 12 1 8943 8952 10.1080/21655979.2021.1990194 34702132
    [Google Scholar]
  82. Shen L. Lin C. Lu W. Involvement of the oncogenic small nucleolar RNA SNORA24 in regulation of p53 stability in colorectal cancer. Cell Biol. Toxicol. 2023 39 4 1377 1394 10.1007/s10565‑022‑09765‑7 36087186
    [Google Scholar]
  83. Wu H. Qin W. Lu S. Long noncoding RNA ZFAS1 promoting small nucleolar RNA-mediated 2′-O-methylation via NOP58 recruitment in colorectal cancer. Mol. Cancer 2020 19 1 95 10.1186/s12943‑020‑01201‑w 32443980
    [Google Scholar]
  84. Li S. Xu Z. Sheng J. tRNA-derived small RNA: A novel regulatory small non-coding RNA. Genes 2018 9 5 246 10.3390/genes9050246 29748504
    [Google Scholar]
  85. Wang Y. Weng Q. Ge J. Zhang X. Guo J. Ye G. tRNA-derived small RNAs: Mechanisms and potential roles in cancers. Genes Dis. 2022 9 6 1431 1442 10.1016/j.gendis.2021.12.009 36157501
    [Google Scholar]
  86. Hussain M.S. Sharma S. Kumari A. Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential. Epigenomics 2024 16 23-24 1453 1464 10.1080/17501911.2024.2430170 39601046
    [Google Scholar]
  87. Wu Y. Yang X. Jiang G. 5′-tRF-GlyGCC: A tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis. Genome Med. 2021 13 1 20 10.1186/s13073‑021‑00833‑x 33563322
    [Google Scholar]
  88. Wang X.Y. Zhou Y.J. Chen H.Y. 5’tiRNA-Pro-TGG, a novel tRNA halve, promotes oncogenesis in sessile serrated lesions and serrated pathway of colorectal cancer. World J. Gastrointest. Oncol. 2023 15 6 1005 1018 10.4251/wjgo.v15.i6.1005 37389118
    [Google Scholar]
  89. Tao E.W. Wang H.L. Cheng W.Y. Liu Q.Q. Chen Y.X. Gao Q.Y. A specific tRNA half, 5’tiRNA-His-GTG, responds to hypoxia via the HIF1α/ANG axis and promotes colorectal cancer progression by regulating LATS2. J. Exp. Clin. Cancer Res. 2021 40 1 67 10.1186/s13046‑021‑01836‑7 33588913
    [Google Scholar]
  90. Huang T. Chen C. Du J. A tRF‐5a fragment that regulates radiation resistance of colorectal cancer cells by targeting MKNK1. J. Cell. Mol. Med. 2023 27 24 4021 4033 10.1111/jcmm.17982 37864471
    [Google Scholar]
  91. Tsukamoto M. Iinuma H. Yagi T. Matsuda K. Hashiguchi Y. Circulating exosomal microRNA-21 as a biomarker in each tumor stage of colorectal cancer. Oncology 2017 92 6 360 370 10.1159/000463387 28376502
    [Google Scholar]
  92. Fu F. Jiang W. Zhou L. Chen Z. Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer. Transl. Oncol. 2018 11 2 221 232 10.1016/j.tranon.2017.12.012 29367070
    [Google Scholar]
  93. Guo S. Chen J. Chen F. Zeng Q. Liu W.L. Zhang G. Exosomes derived from Fusobacterium nucleatum-infected colorectal cancer cells facilitate tumour metastasis by selectively carrying miR-1246/92b-3p/27a-3p and CXCL16. Gut 2020 10.1136/gutjnl‑2020‑321187 33172926
    [Google Scholar]
  94. Ogata-Kawata H. Izumiya M. Kurioka D. Circulating exosomal microRNAs as biomarkers of colon cancer. PLoS One 2014 9 4 e92921 10.1371/journal.pone.0092921 24705249
    [Google Scholar]
  95. Du G. Ren C. Wang J. Ma J. The clinical value of blood miR-654-5p, miR-126, miR-10b, and miR-144 in the diagnosis of colorectal cancer. Comput. Math. Methods Med. 2022 2022 1 8 10.1155/2022/8225966 36277010
    [Google Scholar]
  96. Mo W.Y. Cao S.Q. MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer. Clin. Transl. Oncol. 2022 25 3 563 577 10.1007/s12094‑022‑02978‑6 36355327
    [Google Scholar]
  97. Liu T. Zhang X. Gao S. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Oncotarget 2016 7 51 85551 85563 10.18632/oncotarget.13465 27888803
    [Google Scholar]
  98. Xie Z. Xia J. Jiao M. Exosomal lncRNA HOTAIR induces PDL1+ B cells to impede anti-tumor immunity in colorectal cancer. Biochem. Biophys. Res. Commun. 2023 644 112 121 10.1016/j.bbrc.2023.01.005 36640665
    [Google Scholar]
  99. Xu J. Xiao Y. Liu B. Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway. J. Exp. Clin. Cancer Res. 2020 39 1 54 10.1186/s13046‑020‑01562‑6 32209115
    [Google Scholar]
  100. Yang Y. Zhang R. Du J. Predictive role of UCA1-containing exosomes in cetuximab-resistant colorectal cancer. Cancer Cell Int. 2018 18 1 164 10.1186/s12935‑018‑0660‑6 30377411
    [Google Scholar]
  101. Ng C.T. Azwar S. Yip W.K. Isolation and identification of long non-coding RNAs in exosomes derived from the serum of colorectal carcinoma patients. Biology (Basel) 2021 10 9 918 10.3390/biology10090918 34571795
    [Google Scholar]
  102. Zhao H. Chen S. Fu Q. Exosomes from CD133 + cells carrying circ‐ABCC1 mediate cell stemness and metastasis in colorectal cancer. J. Cell. Biochem. 2020 121 5-6 3286 3297 10.1002/jcb.29600 31960989
    [Google Scholar]
  103. Xu Y. Qiu A. Peng F. Tan X. Wang J. Gong X. Exosomal transfer of circular RNA FBXW7 ameliorates the chemoresistance to oxaliplatin in colorectal cancer by sponging miR-18b-5p. Neoplasma 2021 68 1 108 118 10.4149/neo_2020_200417N414 33147048
    [Google Scholar]
  104. Zhang Y. Li C. Liu X. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637. EBioMedicine 2019 48 277 288 10.1016/j.ebiom.2019.09.051 31631038
    [Google Scholar]
  105. Xu R. Du A. Deng X. tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB. J. Exp. Clin. Cancer Res. 2024 43 1 230 10.1186/s13046‑024‑03132‑6 39153969
    [Google Scholar]
  106. Tan L. Wu X. Tang Z. The tsRNAs (tRFdb-3013a/b) serve as novel biomarkers for colon adenocarcinomas. Aging (Albany NY) 2024 16 5 4299 4326 10.18632/aging.205590 38451187
    [Google Scholar]
  107. Huang B. Yang H. Cheng X. tRF/miR-1280 suppresses stem cell–like cells and metastasis in colorectal cancer. Cancer Res. 2017 77 12 3194 3206 10.1158/0008‑5472.CAN‑16‑3146 28446464
    [Google Scholar]
  108. Zaky M.Y. Hamdalla H.M. Role of exosomal non-coding RNAs in vivo and in vitro studies in colorectal cancer. MicroRNA 2025 10.2174/0122115366331268250303031240 40108898
    [Google Scholar]
  109. Jiang J. Lin F. Wu W. Exosomal long non-coding RNAs in lung cancer.A review. Medicine 2024 103 51 e38492 10.1097/MD.0000000000038492 39705424
    [Google Scholar]
  110. Ma T. Jiang J. Shi M. Xu H. Exosomal miRNA-166-5p derived from G-MDSCs promotes proliferation by targeting ITM3E in colorectal cancer. Environ. Toxicol. 2024 39 2 803 814 10.1002/tox.23980 37792719
    [Google Scholar]
  111. Chang Y. Huang Z. Hou F. Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression. J. Exp. Clin. Cancer Res. 2023 42 1 13 10.1186/s13046‑022‑02572‑2 36627634
    [Google Scholar]
  112. Shi W. Liu Y. Qiu X. Yang L. Lin G. Cancer-associated fibroblasts-derived exosome-mediated transfer of miR-345-5p promotes the progression of colorectal cancer by targeting CDKN1A. Carcinogenesis 2023 44 4 317 327 10.1093/carcin/bgad014 37052230
    [Google Scholar]
  113. Li F. Zhang M. Yin X. Zhang W. Li H. Gao C. Exosomes-derived miR-548am-5p promotes colorectal cancer progression. Cell. Mol. Biol. 2023 69 12 104 110 10.14715/cmb/2023.69.12.17 38063109
    [Google Scholar]
  114. Jiang Y. Qiu Q. Jing X. Cancer-associated fibroblast-derived exosome miR-181b-3p promotes the occurrence and development of colorectal cancer by regulating SNX2 expression. Biochem. Biophys. Res. Commun. 2023 641 177 185 10.1016/j.bbrc.2022.12.026 36535076
    [Google Scholar]
  115. Wu Y. Zhang J. Lin F. Exosomal miR‐1470 is a diagnostic biomarker and promotes cell proliferation and metastasis in colorectal cancer. Cancer Med. 2024 13 7 e7117 10.1002/cam4.7117 38545812
    [Google Scholar]
  116. Yang L.M. Zheng Q. Liu X.J. Exosome-transmitted miR-224-5p promotes colorectal cancer cell proliferation via targeting ULK2 in p53-dependent manner. Biomed. Environ. Sci. 2024 37 1 71 84 38326722
    [Google Scholar]
  117. Liao X. Li T. Yang L. Tumor-derived exosomal circular RNA pinin induces FGF13 expression to promote colorectal cancer progression through miR-1225-5p. Gut Liver 2024 18 6 1014 1025 10.5009/gnl230304 38384181
    [Google Scholar]
  118. Chen J. Wang H. Xu J. CircZFR promotes colorectal cancer progression via stabilizing BCLAF1 and regulating the miR-3127-5p/RTKN2 axis. Sci. China Life Sci. 2024 67 9 1881 1898 10.1007/s11427‑023‑2514‑y 38805063
    [Google Scholar]
  119. Yu Q. Zhang Y. Tian Y. Exosomal Circ_FMN2 derived from the serum of colorectal cancer patients promotes cancer progression by miR-338-3p/MSI1 axis. Appl. Biochem. Biotechnol. 2023 195 12 7322 7337 10.1007/s12010‑023‑04456‑3 36995659
    [Google Scholar]
  120. Li Y. Jiang D. Zhang Z.X. Colorectal cancer cell-secreted exosomal miRNA N-72 promotes tumor angiogenesis by targeting CLDN18. Am. J. Cancer Res. 2023 13 8 3482 3499 37693144
    [Google Scholar]
  121. Liu K. Dou R. Yang C. Exosome-transmitted miR-29a induces colorectal cancer metastasis by destroying the vascular endothelial barrier. Carcinogenesis 2023 44 4 356 367 10.1093/carcin/bgad013 36939367
    [Google Scholar]
  122. Zhang M. Wang Y. Yu L. Fusobacterium nucleatum promotes colorectal cancer metastasis by excretion of miR-122-5p from cells via exosomes. iScience 2023 26 9 107686 10.1016/j.isci.2023.107686 37694140
    [Google Scholar]
  123. Wu L. Xue M. Lai S. Hypoxia derived exosomes promote the proliferation and metastasis of colorectal cancer through the regulation of HIF-1α/miR-4299/ZBTB4. Life Sci. 2023 329 121872 10.1016/j.lfs.2023.121872 37352917
    [Google Scholar]
  124. Liang Y. Li J. Li T. Colorectal cancer cells with high metastatic potential drive metastasis by transmitting exosomal miR-20a-3p through modulating NF1/MAPK pathway. Carcinogenesis 2024 45 10 773 785 10.1093/carcin/bgae036 38829328
    [Google Scholar]
  125. Ghofrani-Shahpar M. Pakravan K. Razmara E. Cancer-associated fibroblasts drive colorectal cancer cell progression through exosomal miR-20a-5p-mediated targeting of PTEN and stimulating interleukin-6 production. BMC Cancer 2024 24 1 400 10.1186/s12885‑024‑12190‑0 38561726
    [Google Scholar]
  126. Wu Y. Zhang J. Li G. Exosomal miR-320d promotes angiogenesis and colorectal cancer metastasis via targeting GNAI1 to affect the JAK2/STAT3 signaling pathway. Cell Death Dis. 2024 15 12 913 10.1038/s41419‑024‑07297‑y 39695099
    [Google Scholar]
  127. Zhang J. Pan Y. Jin L. Yang H. Cao P. Exosomal‐miR‐522‐3p derived from cancer‐associated fibroblasts accelerates tumor metastasis and angiogenesis via repression bone morphogenetic protein 5 in colorectal cancer. J. Gastroenterol. Hepatol. 2024 39 1 107 120 10.1111/jgh.16345 37984826
    [Google Scholar]
  128. Huang L. Yang G. Shao Y. Cancer-derived exosomal lncRNA SNHG3 promotes the metastasis of colorectal cancer through hnRNPC-mediating RNA stability of β-catenin. Int. J. Biol. Sci. 2024 20 7 2388 2402 10.7150/ijbs.88313 38725844
    [Google Scholar]
  129. Ding A.X. Wang H. Zhang J.M. Yang W. Kuang Y.T. lncRNA BANCR promotes the colorectal cancer metastasis through accelerating exosomes-mediated M2 macrophage polarization via regulating RhoA/ROCK signaling. Mol. Cell. Biochem. 2024 479 1 13 27 10.1007/s11010‑023‑04709‑z 36988779
    [Google Scholar]
  130. Payervand N. Pakravan K. Razmara E. Exosomal circ_0084043 derived from colorectal cancer-associated fibroblasts promotes in vitro endothelial cell angiogenesis by regulating the miR-140–3p/HIF-1α/VEGF signaling axis. Heliyon 2024 10 11 e31584 10.1016/j.heliyon.2024.e31584 38828320
    [Google Scholar]
  131. Meng Q. Xiang H. Wang Y. Exosomes containing circSCP2 in colorectal cancer promote metastasis via sponging miR-92a-1-5p and interacting with PTBP1 to stabilize IGF2BP1. Biol. Direct 2024 19 1 130 10.1186/s13062‑024‑00571‑1 39702234
    [Google Scholar]
  132. Hu G. Lin C. Gao K. Chen M. Long F. Tian B. Exosomal circCOL1A1 promotes angiogenesis via recruiting EIF4A3 protein and activating Smad2/3 pathway in colorectal cancer. Mol. Med. 2023 29 1 155 10.1186/s10020‑023‑00747‑x 37940881
    [Google Scholar]
  133. Miao Z. Zhao X. Liu X. Exosomal circCOL1A2 from cancer cells accelerates colorectal cancer progression via regulating miR-665/LASP1 signal axis. Eur. J. Pharmacol. 2023 950 175722 10.1016/j.ejphar.2023.175722 37059374
    [Google Scholar]
  134. Yue C.F. Chen J.G. Li Z.Y. Tumor cell-derived exosomes mediating hsa_circ_0001739/lncRNA AC159540.1 facilitate liver metastasis in colorectal cancer. Cell Biol. Toxicol. 2023 39 6 2551 2568 10.1007/s10565‑023‑09837‑2 37957486
    [Google Scholar]
  135. Chen C. Liu Y. Liu L. Exosomal circTUBGCP4 promotes vascular endothelial cell tipping and colorectal cancer metastasis by activating Akt signaling pathway. J. Exp. Clin. Cancer Res. 2023 42 1 46 10.1186/s13046‑023‑02619‑y 36793126
    [Google Scholar]
  136. Hu J.H. Tang H.N. Wang Y.H. Cancer-associated fibroblast exosome LINC00355 promotes epithelial-mesenchymal transition and chemoresistance in colorectal cancer through the miR-34b-5p/CRKL axis. Cancer Gene Ther. 2024 31 2 259 272 10.1038/s41417‑023‑00700‑4 38052858
    [Google Scholar]
  137. Zhu S. Mao J. Zhang X. CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer. Dig. Liver Dis. 2024 56 2 330 342 10.1016/j.dld.2023.06.010 37400281
    [Google Scholar]
  138. Zhang X. Ma D. Xuan B. LncRNA CACClnc promotes chemoresistance of colorectal cancer by modulating alternative splicing of RAD51. Oncogene 2023 42 17 1374 1391 10.1038/s41388‑023‑02657‑y 36906654
    [Google Scholar]
  139. Hui B. Zhou C. Xu Y. Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085. J. Nanobiotechnology 2024 22 1 62 10.1186/s12951‑024‑02331‑9 38360615
    [Google Scholar]
  140. Yang C. Zhang Y. Yan M. Exosomes derived from cancer-associated fibroblasts promote tumorigenesis, metastasis and chemoresistance of colorectal cancer by upregulating circ_0067557 to target Lin28. BMC Cancer 2024 24 1 64 10.1186/s12885‑023‑11791‑5 38216964
    [Google Scholar]
  141. Qiao X.X. Shi H.B. Xiao L. Serum exosomal hsa-circ-0004771 modulates the resistance of colorectal cancer to 5-fluorouracil via regulating miR-653/ZEB2 signaling pathway. Cancer Cell Int. 2023 23 1 243 10.1186/s12935‑023‑03072‑9 37845688
    [Google Scholar]
  142. Shi X. Wei K. Wu Y. Exosome-derived miR-372-5p promotes stemness and metastatic ability of CRC cells by inducing macrophage polarization. Cell. Signal. 2023 111 110884 10.1016/j.cellsig.2023.110884 37690660
    [Google Scholar]
  143. Pei W. Wei K. Wu Y. Colorectal cancer tumor cell-derived exosomal miR-203a-3p promotes CRC metastasis by targeting PTEN-induced macrophage polarization. Gene 2023 885 147692 10.1016/j.gene.2023.147692 37562585
    [Google Scholar]
  144. Liang Y. Li J. Yuan Y. Exosomal miR-106a-5p from highly metastatic colorectal cancer cells drives liver metastasis by inducing macrophage M2 polarization in the tumor microenvironment. J. Exp. Clin. Cancer Res. 2024 43 1 281 10.1186/s13046‑024‑03204‑7 39385295
    [Google Scholar]
  145. Khan A. Ahmed E. Elareer N. Junejo K. Steinhoff M. Uddin S. Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies. Cells 2019 8 8 840 10.3390/cells8080840 31530793
    [Google Scholar]
  146. Kim J.O. Jun H.H. Kim E.J. Genetic variants of HOTAIR associated with colorectal cancer susceptibility and mortality. Front. Oncol. 2020 10 72 10.3389/fonc.2020.00072 32117729
    [Google Scholar]
  147. Gao B. Wang L. Wen T. Xie X. Rui X. Chen Q. Colon cancer-derived exosomal lncRNA-XIST promotes M2-like macrophage polarization by regulating PDGFRA. Int. J. Mol. Sci. 2024 25 21 11433 10.3390/ijms252111433 39518984
    [Google Scholar]
  148. Sun Z. Xu Y. Shao B. Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10/STAT3 axis in a colorectal cancer model. J. Immunother. Cancer 2024 12 5 e008491 10.1136/jitc‑2023‑008491 38782541
    [Google Scholar]
  149. Tang Y. Hu S. Li T. Qiu X. Tumor cells-derived exosomal circVCP promoted the progression of colorectal cancer by regulating macrophage M1/M2 polarization. Gene 2023 870 147413 10.1016/j.gene.2023.147413 37028610
    [Google Scholar]
  150. Wang L. Shan Y. Zheng S. Li J. Zhu A. Exosomal circ-CTNNB1 derived from colorectal cancer cells induces N2 polarization of neutrophils to promote colorectal cancer cell growth and immune escape. Biomed. Signal Process. Control 2023 85 104960 10.1016/j.bspc.2023.104960
    [Google Scholar]
  151. Fang G. Xu D. Zhang T. Effects of hsa_circ_0074854 on colorectal cancer progression, construction of a circRNA–miRNA–mRNA network, and analysis of immune infiltration. J. Cancer Res. Clin. Oncol. 2023 149 17 15439 15456 10.1007/s00432‑023‑05315‑8 37644235
    [Google Scholar]
  152. Dana F. Mahjoub S. Shokati Eshkiki Z. Namazi A. Tabaeian S.P. Akbari A. Clinical relevance of plasma-derived exosomal long non-coding RNAs (lncRNAs) CCAT1 and XIST in colorectal cancer patients. Mol. Biol. Res. Commun. 2025 14 2 157 166 40028475
    [Google Scholar]
  153. Rizk N.I. Kassem D.H. Abulsoud A.I. Revealing the role of serum exosomal novel long non-coding RNA NAMPT-AS as a promising diagnostic/prognostic biomarker in colorectal cancer patients. Life Sci. 2024 352 122850 10.1016/j.lfs.2024.122850 38901687
    [Google Scholar]
  154. Han L. Shi W.J. Xie Y.B. Zhang Z.G. Diagnostic value of four serum exosome microRNAs panel for the detection of colorectal cancer. World J. Gastrointest. Oncol. 2021 13 8 970 979 10.4251/wjgo.v13.i8.970 34457199
    [Google Scholar]
  155. Shi Y. Zhuang Y. Zhang J. Chen M. Wu S. Four circulating exosomal miRNAs as novel potential biomarkers for the early diagnosis of human colorectal cancer. Tissue Cell 2021 70 101499 10.1016/j.tice.2021.101499 33550035
    [Google Scholar]
  156. Long F. Tian L. Chai Z. Li J. Tang Y. Liu M. Identification of stage-associated exosome miRNAs in colorectal cancer by improved robust and corroborative approach embedded miRNA-target network. Front. Med. 2022 9 881788 10.3389/fmed.2022.881788 36237545
    [Google Scholar]
  157. Radanova M. Mihaylova G. Tasinov O. New circulating circular RNAs with diagnostic and prognostic potential in advanced colorectal cancer. Int. J. Mol. Sci. 2021 22 24 13283 10.3390/ijms222413283 34948079
    [Google Scholar]
  158. Yin T.F. Du S.Y. Zhao D.Y. Identification of circ_0000375 and circ_0011536 as novel diagnostic biomarkers of colorectal cancer. World J. Clin. Cases 2022 10 11 3352 3368 10.12998/wjcc.v10.i11.3352 35611198
    [Google Scholar]
  159. Zheng R. Zhang K. Tan S. Exosomal circLPAR1 functions in colorectal cancer diagnosis and tumorigenesis through suppressing BRD4 via METTL3–eIF3h interaction. Mol. Cancer 2022 21 1 49 10.1186/s12943‑021‑01471‑y 35164758
    [Google Scholar]
  160. Sun Z. Shi K. Yang S. Effect of exosomal miRNA on cancer biology and clinical applications. Mol. Cancer 2018 17 1 147 10.1186/s12943‑018‑0897‑7 30309355
    [Google Scholar]
  161. Zhang J. Li S. Li L. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 2015 13 1 17 24 10.1016/j.gpb.2015.02.001 25724326
    [Google Scholar]
  162. Aghabozorgi A.S. Ahangari N. Eftekhaari T.E. Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes. J. Cell. Physiol. 2019 234 12 21796 21809 10.1002/jcp.28942 31273798
    [Google Scholar]
  163. Nedaeinia R. Manian M. Jazayeri M.H. Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. Cancer Gene Ther. 2017 24 2 48 56 10.1038/cgt.2016.77 27982021
    [Google Scholar]
  164. Shojaeian A. Naeimi Torshizi S.R. Parsapasand M.S. Harnessing exosomes in theranostic applications: Advancements and insights in gastrointestinal cancer research. Discov. Oncol. 2024 15 1 162 10.1007/s12672‑024‑01024‑x 38743146
    [Google Scholar]
  165. Wang X. Tian L. Lu J. Ng I.O.L. Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle. Oncogenesis 2022 11 1 54 10.1038/s41389‑022‑00431‑5 36109501
    [Google Scholar]
  166. Kim H. Kim E.H. Kwak G. Chi S.G. Kim S.H. Yang Y. Exosomes: Cell-derived nanoplatforms for the delivery of cancer therapeutics. Int. J. Mol. Sci. 2020 22 1 14 10.3390/ijms22010014 33374978
    [Google Scholar]
  167. Johnsen K.B. Gudbergsson J.M. Skov M.N. Pilgaard L. Moos T. Duroux M. A comprehensive overview of exosomes as drug delivery vehicles - Endogenous nanocarriers for targeted cancer therapy. Biochim. Biophys. Acta 2014 1846 1 75 87 24747178
    [Google Scholar]
  168. Duan H. Liu Y. Gao Z. Huang W. Recent advances in drug delivery systems for targeting cancer stem cells. Acta Pharm. Sin. B 2021 11 1 55 70 10.1016/j.apsb.2020.09.016 33532180
    [Google Scholar]
  169. Roy B. Ghose S. Biswas S. Therapeutic strategies for miRNA delivery to reduce hepatocellular carcinoma. Semin. Cell Dev. Biol. 2022 124 134 144 10.1016/j.semcdb.2021.04.006 33926792
    [Google Scholar]
  170. Yang Z. Shi J. Xie J. Large-scale generation of functional mRNA-encapsulating exosomes via cellular nanoporation. Nat. Biomed. Eng. 2019 4 1 69 83 10.1038/s41551‑019‑0485‑1 31844155
    [Google Scholar]
  171. Fu Z. Zhang X. Zhou X. In vivo self-assembled small RNAs as a new generation of RNAi therapeutics. Cell Res. 2021 31 6 631 648 10.1038/s41422‑021‑00491‑z 33782530
    [Google Scholar]
  172. Thapa N. Chwae Y.J. Yoo K.H. Exosomal delivery of TRAIL and miR 335 for the treatment of hepatocellular carcinoma.(Review). Int. J. Mol. Med. 2023 51 1 3 10.3892/ijmm.2022.5206 36416311
    [Google Scholar]
  173. Suda T. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo. World J. Gastroenterol. 2024 30 17 2369 2370 10.3748/wjg.v30.i17.2369 38813056
    [Google Scholar]
  174. Weng J. Li S. Zhu Z. Exploring immunotherapy in colorectal cancer. J. Hematol. Oncol. 2022 15 1 95 10.1186/s13045‑022‑01294‑4 35842707
    [Google Scholar]
  175. Cui G. Towards a precision immune checkpoint blockade immunotherapy in patients with colorectal cancer: Strategies and perspectives. Biomed. Pharmacother. 2022 149 112923 10.1016/j.biopha.2022.112923 36068782
    [Google Scholar]
  176. Han Y.J. Shao C.Y. Yao Y. Immunotherapy of microsatellite stable colorectal cancer: Resistance mechanisms and treatment strategies. Postgrad. Med. J. 2024 100 1184 373 381 10.1093/postmj/qgad136 38211949
    [Google Scholar]
  177. Picard E. Verschoor C.P. Ma G.W. Pawelec G. Relationships between immune landscapes, genetic subtypes and responses to immunotherapy in colorectal cancer. Front. Immunol. 2020 11 369 10.3389/fimmu.2020.00369 32210966
    [Google Scholar]
  178. Xiao J. Li W. Huang Y. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer. BMC Cancer 2021 21 1 282 10.1186/s12885‑021‑07942‑1 33726687
    [Google Scholar]
  179. Kang S.Y. Kim D.G. Ahn S. Ha S.Y. Jang K.T. Kim K.M. Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers. Pathol. Res. Pract. 2022 233 153874 10.1016/j.prp.2022.153874 35405622
    [Google Scholar]
  180. Rizk N.I. Abulsoud A.I. Kamal M.M. Kassem D.H. Hamdy N.M. Exosomal-long non-coding RNAs journey in colorectal cancer: Evil and goodness faces of key players. Life Sci. 2022 292 120325 10.1016/j.lfs.2022.120325 35031258
    [Google Scholar]
  181. Tan E. Sahin I.H. Defining the current role of immune checkpoint inhibitors in the treatment of mismatch repair-deficient/] microsatellite stability-high colorectal cancer and shedding light on future approaches. Expert Rev. Gastroenterol. Hepatol. 2021 15 7 735 742 10.1080/17474124.2021.1886077 33539189
    [Google Scholar]
  182. Yang S. Li X. Recent advances in extracellular vesicles enriched with non-coding RNAs related to cancers. Genes Dis. 2018 5 1 36 42 10.1016/j.gendis.2017.12.001 30258933
    [Google Scholar]
  183. Reese M. Dhayat S.A. Small extracellular vesicle non-coding RNAs in pancreatic cancer: Molecular mechanisms and clinical implications. J. Hematol. Oncol. 2021 14 1 141 10.1186/s13045‑021‑01149‑4 34496946
    [Google Scholar]
  184. Hadad S. Khalaji A. Sarmadian A.J. Sarmadian P.J. Janagard E.M. Baradaran B. Tumor-associated macrophages derived exosomes; From pathogenesis to therapeutic opportunities. Int. Immunopharmacol. 2024 136 112406 10.1016/j.intimp.2024.112406 38850795
    [Google Scholar]
  185. Guan H. Peng R. Fang F. Tumor‐associated macrophages promote prostate cancer progression via exosome‐mediated miR‐95 transfer. J. Cell. Physiol. 2020 235 12 9729 9742 10.1002/jcp.29784 32406953
    [Google Scholar]
  186. Amelimojarad M. AmeliMojarad M, Nazemalhosseini-Mojarad E. Exosomal noncoding RNAs in colorectal cancer: An overview of functions, challenges, opportunities, and clinical applications. Pathol. Res. Pract. 2022 238 154133 10.1016/j.prp.2022.154133 36152568
    [Google Scholar]
  187. Aughton K. Kalirai H. Coupland S.E. MicroRNAs and uveal melanoma: Understanding the diverse role of these small molecular regulators. Int. J. Mol. Sci. 2020 21 16 5648 10.3390/ijms21165648 32781746
    [Google Scholar]
  188. Costanzi E. Simioni C. Varano G. Brenna C. Conti I. Neri L.M. The role of extracellular vesicles as shuttles of RNA and their clinical significance as biomarkers in hepatocellular carcinoma. Genes (Basel) 2021 12 6 902 10.3390/genes12060902 34207985
    [Google Scholar]
  189. Zhang Q. Deng T. Zhang H. Zuo D. Zhu Q. Bai M. Adipocyte-derived exosomal MTTP suppresses ferroptosis and promotes chemoresistance in colorectal cancer. Adv. Sci. 2022 9 28 e2203357 10.1002/advs.202203357 35978266
    [Google Scholar]
  190. Wang S. Zeng Y. Zhou J.M. MicroRNA-1246 promotes growth and metastasis of colorectal cancer cells involving CCNG2 reduction. Mol. Med. Rep. 2016 13 1 273 280 10.3892/mmr.2015.4557 26573378
    [Google Scholar]
  191. Di W. Weinan X. Xin L. Long noncoding RNA SNHG14 facilitates colorectal cancer metastasis through targeting EZH2-regulated EPHA7. Cell Death Dis. 2019 10 7 514 10.1038/s41419‑019‑1707‑x 31273190
    [Google Scholar]
  192. Wu C.W. Ng S.S.M. Dong Y.J. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps. Gut 2012 61 5 739 745 10.1136/gut.2011.239236 21930727
    [Google Scholar]
  193. Chen Q. Xia H.W. Ge X.J. Zhang Y.C. Tang Q.L. Bi F. Serum miR-19a predicts resistance to FOLFOX chemotherapy in advanced colorectal cancer cases. APJCP 2013 14 12 7421 7426 24460313
    [Google Scholar]
  194. Sun J. Jia H. Bao X. Tumor exosome promotes Th17 cell differentiation by transmitting the lncRNA CRNDE-h in colorectal cancer. Cell Death Dis. 2021 12 1 123 10.1038/s41419‑020‑03376‑y 33495437
    [Google Scholar]
  195. Maierthaler M. Benner A. Hoffmeister M. Plasma miR‐122 and miR‐200 family are prognostic markers in colorectal cancer. Int. J. Cancer 2017 140 1 176 187 10.1002/ijc.30433 27632639
    [Google Scholar]
  196. Hao J.P. Ma A. The ratio of miR-21/miR-24 as a promising diagnostic and poor prognosis biomarker in colorectal cancer. Eur. Rev. Med. Pharmacol. Sci. 2018 22 24 8649 8656 30575905
    [Google Scholar]
/content/journals/cpd/10.2174/0113816128415658251125090944
Loading
Unlocking the Role of Exosomal ncRNAs in Colorectal Cancer: Molecular Insights and Clinical Promise
Bentham Science Publishers ; https://doi.org/10.2174/0113816128415658251125090944
/content/journals/cpd/10.2174/0113816128415658251125090944
/content/journals/cpd/10.2174/0113816128415658251125090944
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: Colorectal cancer ; non-coding RNAs ; microsatellite ; therapeutic targeting ; exosomes ; biomarkers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test